Vertex Pharmaceuticals | Der Umsatz



Sales Veränderung Datum
AbbVie USD 15.1B 642M 2024-12
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
J&J USD 22.52B 49M 2024-12
Merck USD 15.62B 1.03B 2024-12
Moderna USD 966M 896M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Pfizer USD 17.76B 61M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 735.9M 13M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Vertex Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.